UniProt ID ▲ | Protein Name | Gene Symbol | No. of Glycosylation Sites | No. of GlyTouCan IDs | Disease Ontology |
---|---|---|---|---|---|
P01590 | Interleukin-2 receptor subunit alpha |
|
3 | 0 |
|
P01592 | Immunoglobulin J chain |
|
1 | 6 |
|
P01731 | T-cell surface glycoprotein CD8 alpha chain |
|
3 | 0 |
|
P01758 | Ig heavy chain V region 108A |
|
0 | 1 |
|
P01831 | Thy-1 membrane glycoprotein |
|
3 | 46 |
|
P01837 | Immunoglobulin kappa constant |
|
0 | 1 |
|
P01849 | T-cell receptor alpha chain constant |
|
3 | 0 |
|
P01863 | Ig gamma-2A chain C region, A allele |
|
1 | 0 |
|
P01865 | Ig gamma-2A chain C region, membrane-bound form |
|
1 | 0 |
|
P01867 | Immunoglobulin heavy constant gamma 2B |
|
2 | 6 |
|
P01868 | Ig gamma-1 chain C region secreted form |
|
1 | 8 |
|
P01869 | Ig gamma-1 chain C region, membrane-bound form |
|
1 | 9 |
|
P01872 | Immunoglobulin heavy constant mu |
|
7 | 11 |
|
P01887 | Beta-2-microglobulin |
|
0 | 1 |
|
P01895 | H-2 class I histocompatibility antigen, alpha chain (Fragment) |
|
2 | 0 |
|
P01897 | H-2 class I histocompatibility antigen, L-D alpha chain |
|
3 | 0 |
|
P01898 | H-2 class I histocompatibility antigen, Q10 alpha chain |
|
2 | 0 |
|
P01899 | H-2 class I histocompatibility antigen, D-B alpha chain |
|
3 | 1 |
|
P01900 | H-2 class I histocompatibility antigen, D-D alpha chain |
|
2 | 0 |
|
P01901 | H-2 class I histocompatibility antigen, K-B alpha chain |
|
3 | 3 |
|
P01902 | H-2 class I histocompatibility antigen, K-D alpha chain |
|
3 | 1 |
|
P01904 | H-2 class II histocompatibility antigen, E-D alpha chain |
|
1 | 0 |
|
P01910 | H-2 class II histocompatibility antigen, A-K alpha chain |
|
2 | 2 |
|
P01921 | H-2 class II histocompatibility antigen, A-D beta chain |
|
1 | 1 |
|
P01942 | Hemoglobin subunit alpha |
|
1 | 1 |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024